Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress.
In this study we addressed the function of the Krebs cycle to determine which enzyme(s) limits the availability of reduced nicotinamide adenine dinucleotide (NADH) for the respiratory chain under H(2)O(2)-induced oxidative stress, in intact isolated nerve terminals. The enzyme that was most vulnerable to inhibition by H(2)O(2) proved to be aconitase, being completely blocked at 50 microm H(2)O(2). alpha-Ketoglutarate dehydrogenase (alpha-KGDH) was also inhibited but only at higher H(2)O(2) concentrations (>/=100 microm), and only partial inactivation was achieved. The rotenone-induced increase in reduced nicotinamide adenine dinucleotide (phosphate) [NAD(P)H] fluorescence reflecting the amount of NADH available for the respiratory chain was also diminished by H(2)O(2), and the effect exerted at small concentrations (</=50 microm) of the oxidant was completely prevented by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), an inhibitor of glutathione reductase. BCNU-insensitive decline by H(2)O(2) in the rotenone-induced NAD(P)H fluorescence correlated with inhibition of alpha-ketoglutarate dehydrogenase. Decrease in the glutamate content of nerve terminals was induced by H(2)O(2) at concentrations inhibiting aconitase. It is concluded that (1) aconitase is the most sensitive enzyme in the Krebs cycle to inhibition by H(2)O(2), (2) at small H(2)O(2) concentrations (</=50 microm) when aconitase is inactivated, glutamate fuels the Krebs cycle and NADH generation is unaltered, (3) at higher H(2)O(2) concentrations (>/=100 microm) inhibition of alpha-ketoglutarate dehydrogenase limits the amount of NADH available for the respiratory chain, and (4) increased consumption of NADPH makes a contribution to the H(2)O(2)-induced decrease in the amount of reduced pyridine nucleotides. These results emphasize the importance of alpha-KGDH in impaired mitochondrial function under oxidative stress, with implications for neurodegenerative diseases and cell damage induced by ischemia/reperfusion.
Tretter
L
L
Department of Medical Biochemistry, Neurochemical Group, Semmelweis University of Medicine, Budapest, H-1444, Hungary.
Adam-Vizi
V
V
D000154:Aconitate Hydratase / Q000037:antagonists & inhibitors / Q000378:metabolism; D000818:Animals; D002330:Carmustine / Q000494:pharmacology; D002540:Cerebral Cortex / Q000737:chemistry / Q000201:enzymology; D002950:Citrate (si)-Synthase / Q000378:metabolism / Q000502:physiology; D002952:Citric Acid Cycle / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004579:Electron Transport / Q000187:drug effects; D004789:Enzyme Activation / Q000187:drug effects; D005947:Glucose / Q000378:metabolism; D018698:Glutamic Acid / Q000378:metabolism; D005980:Glutathione Reductase / Q000037:antagonists & inhibitors / Q000378:metabolism; D006168:Guinea Pigs; D006861:Hydrogen Peroxide / Q000494:pharmacology*; D007655:Ketoglutarate Dehydrogenase Complex / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008291:Malate Dehydrogenase / Q000378:metabolism; D009243:NAD / Q000096:biosynthesis*; D009249:NADP / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects*; D011743:Pyrimidines / Q000378:metabolism; D012402:Rotenone / Q000494:pharmacology; D013050:Spectrometry, Fluorescence; D013385:Succinate Dehydrogenase / Q000378:metabolism; D013574:Synaptosomes / Q000737:chemistry / Q000201:enzymology
D011743:Pyrimidines; D012402:Rotenone; D009243:NAD; D018698:Glutamic Acid; D009249:NADP; D006861:Hydrogen Peroxide; D008291:Malate Dehydrogenase; D007655:Ketoglutarate Dehydrogenase Complex; D013385:Succinate Dehydrogenase; D005980:Glutathione Reductase; D002950:Citrate (si)-Synthase; D000154:Aconitate Hydratase; D005947:Glucose; D002330:Carmustine